Royal Bank of Canada’s TuHURA Biosciences HURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6K Buy
3,263
+1,787
+121% +$2.19K ﹤0.01% 6389
2025
Q4
$1K Buy
1,476
+891
+152% +$1.71K ﹤0.01% 7084
2025
Q3
$1K Buy
585
+465
+388% +$1.22K ﹤0.01% 7059
2025
Q2
$0 Buy
+120
New +$405 ﹤0.01% 7441
2023
Q2
Hold
0
7738
2023
Q1
Hold
0
7580
2021
Q3
Hold
0
-$1K 7923
2021
Q2
Hold
0
7358
2021
Q1
Hold
0
7334
2019
Q4
Hold
0
7187
2019
Q3
Hold
0
7209
2019
Q2
Hold
0
7260
2019
Q1
Hold
0
7165
2018
Q4
Hold
0
7179
2018
Q3
Hold
0
6992
2018
Q2
Hold
0
6819
2018
Q1
Hold
0
6864

Other funds holding HURA

Royal Bank of Canada's HURA Position: Q1 2026 in Review

Royal Bank of Canada increased its TuHURA Biosciences (HURA) stake by 121% in Q1 2026, buying an estimated $2.19K and bringing the position to 3,263 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #6389.

Royal Bank of Canada first reported a position in HURA in Q2 2025 and has held it in 4 quarters since. 89 funds tracked by Wall St. Rank hold HURA as of Q1 2026.

  • Royal Bank of Canada held 3,263 shares of TuHURA Biosciences worth $6K as of Q1 2026.
  • Royal Bank of Canada bought 1,787 TuHURA Biosciences shares in Q1 2026, an estimated $2.19K.
  • TuHURA Biosciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6389 holding.
  • Royal Bank of Canada first reported a position in TuHURA Biosciences in Q2 2025 and has held it in 4 quarters since.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.